Describe your research in non-technical language
I have over 30 years of experience in the planning and analysis of clinical trials, observational studies, and community-based projects. I have an extensive background in collaborating with researchers in a broad range of areas in biomedical research, including cardiovascular disease, cystic fibrosis, cancer, aging, pediatrics, and minority health. I conduct statistical research in linear and generalized linear mixed model methodology with a focus on longitudinal data analysis.
What drew you into the field of research you are in?
I was drawn into biostatistics because I wanted to use my mathematical and statistical education to have a positive impact on peoples’ lives and I felt strongly that biostatistics was the right choice for me.
What brought you to the UAB School of Public Health?
I came to UAB as Chair of the Department of Biostatistics in 2017.
What is the most exciting project you are currently working on?
The most exciting project I am working on is the Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trials (CREST-2). In the past year, we have collaborated to produce the primary outcome paper in the New England Journal of Medicine and two secondary outcome papers in the Journal of the American Medical Association.
What professional accomplishment(s) are you most proud of so far in your career?
My proudest professional accomplishment has been my role as a teacher and mentor.
In your career so far, how have you been able to overcome unforeseen challenges? What advice would you give to other investigators meeting unforeseen challenges?
I have attempted to address unforeseen challenges by staying calm, applying intelligence, and seeking help whenever possible. It is important to have some degree of intestinal fortitude in a career in higher education.
How do you see your field evolving in the next five years?
Advancement in the computational ability to process complex biomedical data and artificial intelligence will play a pivotal role in helping the field of biostatistics evolve in the next five years.